Literature DB >> 1517464

Transfusion associated graft versus host disease in an immunocompetent patient.

N T O'Connor1, P Mackintosh.   

Abstract

Transfusion associated graft versus host disease is a rare disorder usually confined to patients who are immunosuppressed. A case is described in a 77 year old woman who was presumed immunocompetent. She was transfused with one unit of blood from an individual who was homozygous for the same HLA haplotype as her. The diagnosis of transfusion associated graft versus host disease should be suspected in a patient who develops aplastic anaemia within 30 days of a transfusion of blood products. It is suggested that blood donations from first degree relatives should not be permitted, unless the donation is irradiated to prevent lymphocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517464      PMCID: PMC495192          DOI: 10.1136/jcp.45.7.621

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Transfusion-associated graft-versus-host disease in an immunocompetent patient.

Authors:  S M Capon; W D DePond; D B Tyan; S H Pepkowitz; H Toyoda; A C Cinman; P C Azer; D Goldfinger
Journal:  Ann Intern Med       Date:  1991-06-15       Impact factor: 25.391

2.  Transfusion-associated graft-versus-host disease in nonimmunocompromised hosts.

Authors:  G B Vogelsang
Journal:  Transfusion       Date:  1990-02       Impact factor: 3.157

3.  Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan.

Authors:  T Juji; K Takahashi; Y Shibata; H Ide; T Sakakibara; T Ino; S Mori
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

4.  Transfusion-induced graft versus host disease in pregnancy.

Authors:  T Sheehan; K M McLaren; R Brettle; A C Parker
Journal:  Clin Lab Haematol       Date:  1987
  4 in total
  2 in total

1.  Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response.

Authors:  Rachael P Jackman; Xutao Deng; Douglas Bolgiano; Garth H Utter; Cathy Schechterly; Mila Lebedeva; Eva Operskalski; Naomi L Luban; Harvey Alter; Michael P Busch; Sherrill J Slichter; Philip J Norris
Journal:  Transfusion       Date:  2013-06-30       Impact factor: 3.157

2.  Prevention of transfusion-associated graft-versus-host disease by irradiation: technical aspect of a new ferrous sulphate dosimetric system.

Authors:  Lucas Sacchini Del Lama; Evamberto Garcia de Góes; Paulo César Dias Petchevist; Edson Lara Moretto; José Carlos Borges; Dimas Tadeu Covas; Adelaide de Almeida
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.